Fulgent (FLGT)

Registration Deadline:

Submit Your Information

Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating Fulgent Genetics Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”) for potential violations of federal securities laws.

On February 27, 2026, Fulgent reported its fourth quarter and full year 2025 financial results. The Company disclosed that full year 2025 revenue was approximately $322.7 million, which fell slightly short of the updated guidance previously provided. Fulgent also reported that fourth quarter revenue declined sequentially.

If you suffered a loss in Fulgent, and wish to participate, learn more, or discuss the issues surrounding the investigation, please contact our attorneys Andrea Farah at (914) 733-7256 or via email to afarah@lowey.com or Vincent R. Cappucci Jr. at (914) 733-7278 or via email at vcappucci@lowey.com.

About Lowey Dannenberg

Lowey Dannenberg is a national firm representing institutional and individual investors, who suffered financial losses resulting from corporate fraud and malfeasance in violation of federal securities and antitrust laws. The firm has significant experience in prosecuting multi-million-dollar lawsuits and has previously recovered billions of dollars on behalf of investors.

If you suffered a loss on your investments or would like to inquire about joining an action to recover your loss under the federal securities laws, please complete the form below.

An attorney will contact you at no cost to provide you information about joining the action and answer your questions. Please note that submission of this form does not by itself form an attorney-client relationship nor does filing out this form mean you have joined any lawsuit.

=